The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-hydroxy-2-(3'-benzyl-2',5'-dioxo-6,7,8,9-tetrahydrospiro[benzo[7]annulene-5,4'-imidazolidin]-1'-yl)acetamide ID: ALA4475849
PubChem CID: 155537935
Max Phase: Preclinical
Molecular Formula: C22H23N3O4
Molecular Weight: 393.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CN1C(=O)N(Cc2ccccc2)C2(CCCCc3ccccc32)C1=O)NO
Standard InChI: InChI=1S/C22H23N3O4/c26-19(23-29)15-24-20(27)22(13-7-6-11-17-10-4-5-12-18(17)22)25(21(24)28)14-16-8-2-1-3-9-16/h1-5,8-10,12,29H,6-7,11,13-15H2,(H,23,26)
Standard InChI Key: JGZSTJKMFWQYDD-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
23.1322 -17.5316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7236 -18.7904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5408 -18.7904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.7952 -18.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4735 -18.0137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2425 -19.4509 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5727 -17.7622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2425 -19.1990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9517 -18.7930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6579 -19.2042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9547 -17.9758 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.6549 -20.0214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.7133 -15.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5296 -15.7354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0451 -16.3756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8696 -17.1753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3899 -17.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2049 -16.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4224 -16.1448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8241 -16.7048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0137 -17.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7959 -17.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6556 -18.0112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2448 -18.7177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4273 -18.7105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0167 -19.4161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4232 -20.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2446 -20.1259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6516 -19.4197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 1 1 0
1 5 1 0
5 2 1 0
2 6 2 0
4 7 2 0
3 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
13 14 1 0
14 15 1 0
13 18 1 0
15 16 1 0
16 1 1 0
17 1 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
5 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.44Molecular Weight (Monoisotopic): 393.1689AlogP: 2.58#Rotatable Bonds: 4Polar Surface Area: 89.95Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.75CX Basic pKa: ┄CX LogP: 2.78CX LogD: 2.76Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -0.55
References 1. Giannakopoulou E, Pardali V, Frakolaki E, Siozos V, Myrianthopoulos V, Mikros E, Taylor MC, Kelly JM, Vassilaki N, Zoidis G.. (2019) Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species., 10 (6): [PMID:31303998 ] [10.1039/C9MD00200F ]